In a large NGS project involving more than 10,000 patients with metastatic cancer, TP53, KRAS, RB1 and PIK3CA were among the top 10 most commonly mutated genes in 62 major solid tumor entities [37]. The gene discussed is RB1; the disease is metastatic malignant neoplasm.